Breast Cancer Clinical Trial
Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study
Summary
This research study is evaluating ear acupuncture as a possible treatment to reduce symptoms related to receiving chemotherapy.
Full Description
Chemotherapy drugs used to treat cancer can cause many symptoms. Some of the most common symptoms of receiving chemotherapy are nausea, vomiting, and anxiety. These symptoms can affect the quality of life of cancer patients. Medications can help ease these, but many patients continue to experience symptoms despite these treatments.
Acupuncture has been studied in clinical trials in cancer patients and has been shown to be helpful for management of pain, nerve damage from chemotherapy, and nausea.
Ear acupuncture is a type of acupuncture that involves the stimulation of points on the external ear. A few studies have suggested that ear acupuncture may help to reduce symptoms of nausea and anxiety during chemotherapy.
This study is being done to evaluate the potential benefits of using ear acupuncture to reduce symptoms like nausea and anxiety for women receiving chemotherapy for breast cancer.
Eligibility Criteria
Inclusion Criteria:
History of histologically or cytologically proven Stage I-III breast cancer receiving intravenous chemotherapy on an every 14 days or every 21 days schedule
Age ≥ 18 years
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Signed informed consent
Exclusion Criteria:
Receiving weekly chemotherapy
Unstable cardiac disease or myocardial infarction within 6 months prior to study entry
Uncontrolled seizure disorder
Pregnancy or potential pregnancy
Active clinically significant uncontrolled infection
Prior use of acupuncture within 3 months prior to the study entry
Uncontrolled major psychiatric disorders, such as major depression or psychosis
Metastatic breast or other cancer
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?